Financhill
Back

Cabaletta Bio Quote, Financials, Valuation and Earnings

Cabaletta Bio Price Quote

$11.25
+0.61 (+5.68%)
(Updated: May 1, 2024 at 10:15 AM ET)

Cabaletta Bio Key Stats

Sell
17
Cabaletta Bio (CABA) is a Sell

Day range:
$10.14 - $10.79
52-week range:
$9.02 - $26.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.17%

Volume:
1.9M
Avg. volume:
1.3M
1-year change:
2.55%
Market cap:
$513.5M
Revenue:
$0
EPS:
$-1.66

How Much Does Cabaletta Bio Make?

Data Unavailable

Is Cabaletta Bio Growing As A Company?

Data Unavailable

Cabaletta Bio Stock Price Performance

  • Did Cabaletta Bio Stock Go Up Last Month?
    Cabaletta Bio share price went down by -37.6% last month
  • Did CABA's Share Price Rise Over The Last Year?
    CABA share price rose by 2.55% over the past 1 year

What Is Cabaletta Bio 52-Week High & Low?

Cabaletta Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cabaletta Bio?

  • How Much Debt Does Cabaletta Bio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cabaletta Bio Have?
    Cash and short term investments quarterly total is $241.2M
  • What Is Cabaletta Bio’s Book Value Per Share?
    Book value per share is 5.09

Is Cabaletta Bio Cash Flow Positive?

  • What Is CABA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$53.5M
  • What Is Cabaletta Bio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $187.6M
  • What Is Cabaletta Bio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$22.5M

Cabaletta Bio Return On Invested Capital

Data Unavailable

Cabaletta Bio Earnings Date & Stock Price

Cabaletta Bio Competitors

  • Who Are Cabaletta Bio's Competitors?
    Below is a list of companies who compete with Cabaletta Bio or are related in some way:
    • Amneal Pharmaceuticals Inc (AMRX)
    • Editas Medicine Inc (EDIT)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Cabaletta Bio Dividend Yield

Data Unavailable

Cabaletta Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -17.28%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.50
Upside from Last Price: 224.1%

Major Shareholders

  • How many CABA shares are owned by institutional investors?
    76.3M CABA shares are owned by institutional investors
  • How many CABA shares are owned by insiders?
    1.2M CABA shares are owned by insiders